Evoking exosomes
Evox is making exosomes that can deliver therapies to the brain
Exosomes are emerging as one of the newest technologies for creating diagnostics and delivering therapeutics, primarily in cancer. Evox Therapeutics Ltd. is joining the growing list of start-ups, using science from exosome pioneer Matthew Wood to expand the field to the CNS.
In 2011, Wood’s group published a study in Nature Biotechnology showing it could engineer exosomes to selectively deliver siRNAs to the brain and knock down BACE1, a key target in Alzheimer’s disease. Wood is an Evox co-founder and professor of neuroscience at University of Oxford...